User:Mr. Ibrahem/Thiotepa

Thiotepa, sold under the brand name Tepadina, is a medication primarily used to treat cancer. This includes bladder, breast, ovarian, and lymphoma. Such use; however, is not recommended by Scotland. Other uses include, as an eye drop, for pterygium.

Common side effects include low blood cells, graft-versus-host disease, blood in the urine, and mucosal inflammation. Other side effects may include further cancer and anaphylaxis. Use in pregnancy may harm the baby. It is an alkylating agent and works by giving cells that divide rapidly.

Thiotepa was approved for medical use in the United States in 1959. It was approved in Europe in 2010, though has been used for decades before this. In the United States it costs about 3,600 USD for 100 mg.